Top

European Journal of Nutrition

Published in:

01-08-2011 | Review

Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits

Authors: Ajay Machha, Alan N. Schechter

Published in: European Journal of Nutrition | Issue 5/2011

Abstract

Purpose

In the last decade, a growing scientific and medical interest has emerged toward cardiovascular effects of dietary nitrite and nitrate; however, many questions concerning their mode of action(s) remain unanswered. In this review, we focus on multiple mechanisms that might account for potential cardiovascular beneficial effects of dietary nitrite and nitrate.

Results

Beneficial changes to cardiovascular health from dietary nitrite and nitrate might result from several mechanism(s) including their reduction into nitric oxide, improvement in endothelial function, vascular relaxation, and/or inhibition of the platelet aggregation. From recently obtained evidence, it appears that the longstanding concerns about the toxicity of oral nitrite or nitrate are overstated.

Conclusion

Dietary nitrite and nitrate may have cardiovascular protective effects in both healthy individuals and also those with cardiovascular disease conditions. A role for nitrite and nitrate in nitric oxide biosynthesis and/or in improving nitric oxide bioavailability may eventually provide a rationale for using dietary nitrite and nitrate supplementation in the treatment and prevention of cardiovascular diseases.

Ness AR, Powles JW (1997) Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol 26:1–13CrossRef

van’t Veer P, Jansen MC, Klerk M, Kok FJ (2000) Fruits and vegetables in the prevention of cancer and cardiovascular disease. Public Health Nutr 3:103–107

Bazzano LA, Serdula MK, Liu S (2003) Dietary intake of fruits and vegetables and risk of cardiovascular disease. Curr Atheroscler Rep 5:492–499CrossRef

Miller ER III, Erlinger TP, Appel LJ (2006) The effects of macronutrients on blood pressure and lipids: an overview of the DASH and OmniHeart trials. Curr Atheroscler Rep 8:460–465CrossRef

Mente A, de Koning L, Shannon HS, Anand SS (2009) A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169:659–669CrossRef

Dauchet L, Amouyel P, Dallongeville J (2009) Fruits, vegetables and coronary heart disease. Nat Rev Cardiol 6:599–608CrossRef

Dejam A, Hunter CJ, Schechter AN, Gladwin MT (2004) Emerging role of nitrite in human biology. Blood Cells Mol Dis 32:423–429CrossRef

Dezfulian C, Raat N, Shiva S, Gladwin MT (2007) Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc Res 75:327–338CrossRef

Kapil V, Webb AJ, Ahluwalia A (2010) Inorganic nitrate and the cardiovascular system. Heart 96:1703–1709CrossRef

10.

Lundberg JO, Weitzberg E, Gladwin MT (2008) The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7:156–167CrossRef

11.

Garg HK, Bryan NS (2009) Dietary sources of nitrite as a modulator of ischemia/reperfusion injury. Kidney Int 75:1140–1144CrossRef

12.

Lundberg JO, Weitzberg E (2009) NO generation from inorganic nitrate and nitrite: role in physiology, nutrition and therapeutics. Arch Pharm Res 32:1119–1126CrossRef

13.

Bryan NS (2009) Cardioprotective actions of nitrite therapy and dietary considerations. Front Biosci 14:4793–4808CrossRef

14.

Carlstrom M, Larsen FJ, Nystrom T, Hezel M, Borniquel S, Weitzberg E, Lundberg JO (2010) Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc Natl Acad Sci U S A 107:17716–17720CrossRef

15.

Dejam A, Hunter CJ, Tremonti C et al (2007) Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation 116:1821–1831CrossRef

16.

Stokes KY, Dugas TR, Tang Y, Garg H, Guidry E, Bryan NS (2009) Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction. Am J Physiol Heart Circ Physiol 296:H1281–H1288CrossRef

17.

Gonzalez FM, Shiva S (2008) Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction. Circulation 117:2986–2994CrossRef

18.

Duranski MR, Greer JJ, Dejam A et al (2005) Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115:1232–1240

19.

Webb A, Bond R, McLean P, Uppal R, Benjamin N, Ahluwalia A (2004) Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci U S A 101:13683–13688CrossRef

20.

Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, Hogg N (2007) Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. J Mol Cell Cardiol 43:437–444CrossRef

21.

Bryan NS, Calvert JW, Gundewar S, Lefer DJ (2008) Dietary nitrite restores NO homeostasis and is cardioprotective in endothelial nitric oxide synthase-deficient mice. Free Radic Biol Med 45:468–474CrossRef

22.

Bryan NS, Calvert JW, Elrod JW, Gundewar S, Ji SY, Lefer DJ (2007) Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A 104:19144–19149CrossRef

23.

Shiva S, Gladwin MT (2009) Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function. Basic Res Cardiol 104:113–119CrossRef

24.

Shiva S, Sack MN, Greer JJ et al (2007) Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204:2089–2102CrossRef

25.

Hunter CJ, Dejam A, Blood AB et al (2004) Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med 10:1122–1127CrossRef

26.

Johnson G III, Tsao PS, Mulloy D, Lefer AM (1990) Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther 252:35–41

27.

Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E (2006) Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med 355:2792–2793CrossRef

28.

Kapil V, Milsom AB, Okorie M et al (2010) Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 56:274–281CrossRef

29.

Cosby K, Partovi KS, Crawford JH et al (2003) Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9:1498–1505CrossRef

30.

Webb AJ, Patel N, Loukogeorgakis S et al (2008) Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51:784–790CrossRef

31.

Thomas DD, Liu X, Kantrow SP, Lancaster JR Jr (2001) The biological lifetime of nitric oxide: Implications for the perivascular dynamics of NO and O₂. Proc Natl Acad Sci U S A 98:355–360CrossRef

32.

Dejam A, Hunter CJ, Pelletier MM et al (2005) Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 106:734–739CrossRef

33.

Shiva S, Wang X, Ringwood LA et al (2006) Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol 2:486–493CrossRef

34.

Kleinbongard P, Dejam A, Lauer T et al (2003) Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 35:790–796CrossRef

35.

Godecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Godecke S, Schrader J (1998) Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 82:186–194

36.

Rhodes P, Leone AM, Francis PL, Struthers AD, Moncada S (1995) The l-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 209:590–596CrossRef

37.

Pennington JAT (1998) Dietary exposure models for nitrates and nitrites. Food Control 9:385–395CrossRef

38.

Duncan C, Dougall H, Johnston P et al (1995) Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med 1:546–551CrossRef

39.

Dougall HT, Smith L, Duncan C, Benjamin N (1995) The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions? Br J Clin Pharmacol 39:460–462

40.

Govoni M, Jansson EA, Weitzberg E, Lundberg JO (2008) The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide 19:333–337CrossRef

41.

Jansson EA, Huang L, Malkey R et al (2008) A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat Chem Biol 4:411–417CrossRef

42.

Kelm M, Preik-Steinhoff H, Preik M, Strauer BE (1999) Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial l-arginine-NO pathway. Cardiovasc Res 41:765–772CrossRef

43.

Rassaf T, Feelisch M, Kelm M (2004) Circulating NO pool: assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med 36:413–422CrossRef

44.

Piknova B, Schechter AN (2011) Measurement of nitrite in blood samples using the ferricyanide-based hemoglobin oxidation assay. Methods Mol Biol 704:39–56CrossRef

45.

Rodriguez J, Maloney RE, Rassaf T, Bryan NS, Feelisch M (2003) Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc Natl Acad Sci U S A 100:336–341CrossRef

46.

Tannenbaum SR, Weisman M, Fett D (1976) The effect of nitrate intake on nitrite formation in human saliva. Food Cosmet Toxicol 14:549–552CrossRef

47.

Bartholomew B, Hill MJ (1984) The pharmacology of dietary nitrate and the origin of urinary nitrate. Food Chem Toxicol 22:789–795CrossRef

48.

Lundberg JO, Govoni M (2004) Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med 37:395–400CrossRef

49.

Pannala AS, Mani AR, Spencer JP, Skinner V, Bruckdorfer KR, Moore KP, Rice-Evans CA (2003) The effect of dietary nitrate on salivary, plasma, and urinary nitrate metabolism in humans. Free Radic Biol Med 34:576–584CrossRef

50.

Cines DB, Pollak ES, Buck CA et al (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527–3561

51.

Quyyumi AA (1998) Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 105:32S–39SCrossRef

52.

Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142

53.

Naseem KM (2005) The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 26:33–65CrossRef

54.

Ajay M, Achike FI, Mustafa AM, Mustafa MR (2006) Direct effects of quercetin on impaired reactivity of spontaneously hypertensive rat aortas: comparative study with ascorbic acid. Clin Exp Pharmacol Physiol 33:345–350CrossRef

55.

Hadi HAR, Carr CS, Suwaidi JA (2005) Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 1:183–198

56.

Hirata Y, Nagata D, Suzuki E, Nishimatsu H, Suzuki J, Nagai R (2010) Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. Int Heart J 51:1–6CrossRef

57.

Benjamin N, O’Driscoll F, Dougall H, Duncan C, Smith L, Golden M, McKenzie H (1994) Stomach NO synthesis. Nature 368:502CrossRef

58.

Lundberg JO, Weitzberg E, Lundberg JM, Alving K (1994) Intragastric nitric oxide production in humans: measurements in expelled air. Gut 35:1543–1546CrossRef

59.

Zweier JL, Wang P, Samouilov A, Kuppusamy P (1995) Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1:804–809CrossRef

60.

Shiva S, Huang Z, Grubina R et al (2007) Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 100:654–661CrossRef

61.

Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR (1998) Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 427:225–228CrossRef

62.

Li H, Liu X, Cui H, Chen YR, Cardounel AJ, Zweier JL (2006) Characterization of the mechanism of cytochrome P450 reductase–cytochrome P450-mediated nitric oxide and nitrosothiol generation from organic nitrates. J Biol Chem 281:12546–12554CrossRef

63.

Castello P, David P, McClure T, Crook Z, Poyton R (2006) Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signalling in eukaryotes. Cell Metab 3:277–287CrossRef

64.

Li H, Kundu TK, Zweier JL (2009) Characterization of the magnitude and mechanism of aldehyde oxidase-mediated nitric oxide production from nitrite. J Biol Chem 284:33850–33858CrossRef

65.

Aamand R, Dalsgaard T, Jensen FB, Simonsen U, Roepstorff A, Fago A (2009) Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol Heart Circ Physiol 297:H2068–H2074CrossRef

66.

Takahama U, Yamamoto A, Hirota S, Oniki T (2003) Quercetin-dependent reduction of salivary nitrite to nitric oxide under acidic conditions and interaction between quercetin and ascorbic acid during the reduction. J Agric Food Chem 51:6014–6020CrossRef

67.

Sibmooh N, Piknova B, Rizzatti F, Schechter AN (2008) Oxidation of iron-nitrosyl-hemoglobin by dehydroascorbic acid releases nitric oxide to form nitrite in human erythrocytes. Biochemistry 47:2989–2996CrossRef

68.

van Faassen EE, Bahrami S, Feelisch M et al (2009) Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 29:683–741CrossRef

69.

Feelisch M, Fernandez BO, Bryan NS et al (2008) Tissue processing of nitrite in hypoxia: an intricate interplay of nitric oxide-generating and -scavenging systems. J Biol Chem 283:33927–33934CrossRef

70.

Kim-Shapiro DB, Schechter AN, Gladwin MT (2006) Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol 26:697–705CrossRef

71.

Gladwin MT, Shelhamer JH, Schechter AN et al (2000) Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A 97:11482–11487CrossRef

72.

Blebea J, Bacik B, Strothman G, Myatt L (1996) Decreased nitric oxide production following extremity ischemia and reperfusion. Am J Surg 172:158–161CrossRef

73.

Ma XL, Weyrich AS, Lefer DJ, Lefer AM (1993) Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72:403–412

74.

Gautier C, van Faassen E, Mikula I, Martasek P, Slama-Schwok A (2006) Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia. Biochem Biophys Res Commun 341:816–821CrossRef

75.

Vanin A, Bevers L, Slama-Schwok A, van Faassen E (2007) Nitric oxide synthase reduces nitrite to NO under anoxia. Cell Mol Life Sci 64:96–103CrossRef

76.

Ballinger SW (2005) Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 38:1278–1295CrossRef

77.

Madamanchi NR, Runge MS (2007) Mitochondrial dysfunction in atherosclerosis. Circ Res 100:460–473CrossRef

78.

Graham D, Huynh NN, Hamilton CA et al (2009) Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54:322–328CrossRef

79.

Landmesser U, Dikalov S, Price SR et al (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111:1201–1209

80.

Milstien S, Katusic Z (1999) Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263:681–684CrossRef

81.

Sattar N (2004) Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease? Clin Sci (Lond) 106:443–445CrossRef

82.

Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I (2009) Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 206:61–68CrossRef

83.

Chrysant SG (2010) The role of angiotensin receptor blocker and calcium channel blocker combination therapy in treating hypertension: focus on recent studies. Am J Cardiovasc Drugs 10:315–320CrossRef

84.

Godfraind T (2006) Calcium-channel modulators for cardiovascular disease. Expert Opin Emerg Drugs 11:49–73CrossRef

85.

Furchgott RF, Bhadrakom S (1953) Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther 108:128–143

86.

Weiss S, Wilkins RW, Haynes FW (1937) The nature of the collapse induced by sodium nitrite. J Clin Invest 16:73–84CrossRef

87.

Jeffers A, Xu X, Huang KT, Cho M, Hogg N, Patel RP, Kim-Shapiro DB (2005) Hemoglobin mediated nitrite activation of soluble guanylyl cyclase. Comp Biochem Physiol A Mol Integr Physiol 142:130–135CrossRef

88.

Laustiola KE, Vuorinen P, Porsti I, Metsa-Ketela T, Manninen V, Vapaatalo H (1991) Exogenous GTP enhances the effects of sodium nitrite on cyclic GMP accumulation, vascular smooth muscle relaxation and platelet aggregation. Pharmacol Toxicol 68:60–63CrossRef

89.

Arnold WP, Mittal CK, Katsuki S, Murad F (1977) Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 74:3203–3207CrossRef

90.

Gruetter CA, Kadowitz PJ, Ignarro LJ (1981) Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol 59:150–156CrossRef

91.

Pinder AG, Pittaway E, Morris K, James PE (2009) Nitrite directly vasodilates hypoxic vasculature via nitric oxide-dependent and -independent pathways. Br J Pharmacol 157:1523–1530CrossRef

92.

Matthew E (1908) Vaso-dilators in high blood pressure. Q J Med 2:261–270

93.

Crandall LA Jr, Leake CD, Loevenhart AS, Muehlberger CW (1931) Acquired tolerance to and cross tolerance between the nitrous and nitric acid esters and sodium nitrite in man. J Pharmacol Exp Ther 41:103–119

94.

Richardson G, Hicks SL, O’Byrne S, Frost MT, Moore K, Benjamin N, McKnight GM (2002) The ingestion of inorganic nitrate increases gastric S-nitrosothiol levels and inhibits platelet function in humans. Nitric Oxide 7:24–29CrossRef

95.

McKnight GM, Duncan CW, Leifert C, Golden MH (1999) Dietary nitrate in man: friend or foe? Br J Nutr 81:349–358CrossRef

96.

Tsuchiya K, Kanematsu Y, Yoshizumi M et al (2005) Nitrite is an alternative source of NO in vivo. Am J Physiol Heart Circ Physiol 288:H2163–H2170CrossRef

97.

Petersson J, Carlstrom M, Schreiber O et al (2009) Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwash. Free Radic Biol Med 46:1068–1075CrossRef

98.

Sobko T, Marcus C, Govoni M, Kamiya S (2010) Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers. Nitric Oxide 22:136–140CrossRef

99.

Kumar D, Branch BG, Pattillo CB et al (2008) Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc Natl Acad Sci U S A 105:7540–7545CrossRef

100.

Jung KH, Chu K, Ko SY et al (2006) Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury. Stroke 37:2744–2750CrossRef

101.

Spiegelhalder B, Eisenbrand G, Preussmann R (1976) Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet Toxicol 14:545–548CrossRef

102.

Lin JK (1990) Nitrosamines as potential environmental carcinogens in man. Clin Biochem 23:67–71CrossRef

103.

National Toxicology Program Technical Report on the toxicology and carcinogenesis studies of sodium nitrite (CAS No. 7632-00-0) in F344/N rats and B6C3F1 mice (drinking water studies) (2001). NIH publication no. 01-3954:7–273

104.

Knight TM, Forman D, Pirastu R et al (1990) Nitrate and nitrite exposure in Italian populations with different gastric cancer rates. Int J Epidemiol 19:510–515CrossRef

105.

Eichholzer M, Gutzwiller F (1998) Dietary nitrates, nitrites, and N-nitroso compounds and cancer risk: a review of the epidemiologic evidence. Nutr Rev 56:95–105CrossRef

106.

Tang Y, Jiang H, Bryan NS (2011) Nitrite and nitrate: cardiovascular risk-benefit and metabolic effect. Curr Opin Lipidol 22:11–15CrossRef

107.

Cross AJ, Ferrucci LM, Risch A et al (2010) A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res 70:2406–2414CrossRef

108.

Ferrucci LM, Sinha R, Ward MH et al (2010) Meat and components of meat and the risk of bladder cancer in the NIH-AARP diet and health study. Cancer 116:4345–4353CrossRef

109.

Anderson L (1994) Abortion and possible risk for breast cancer: analysis and inconsistencies. National Cancer Institute, Bethesda

Title: Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits
Authors: Ajay Machha
Alan N. Schechter
Publication date: 01-08-2011
Publisher: Springer-Verlag
Published in: European Journal of Nutrition / Issue 5/2011
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-011-0192-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2011

Vitamin D deficiency is an independent predictor of elevated triglycerides in Spanish school children

Striking a new path

Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages

Calcium and vitamin D supplementation through fortified dairy products counterbalances seasonal variations of bone metabolism indices: the Postmenopausal Health Study

Successful weight loss and maintenance in everyday clinical practice with an individually tailored change of eating habits on the basis of food energy density

Low-dose lithium uptake promotes longevity in humans and metazoans

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage